Clinical trial Recruiting at 1 site Observational Ages 18 and up

Understanding links between severe periodontitis and gut bacteria and barrier function

Official title: The Intestinal Microbiome: From Systemic Impact to Periodontal Supporting Tissues

Run by Iuliu Hatieganu University of Medicine and Pharmacy · NCT07907224 · Data updated 2026-11-12

This observational study tests whether severe periodontitis is related to small intestinal bacterial overgrowth (SIBO) and changes in gut barrier biomarkers in adults.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorIuliu Hatieganu University of Medicine and Pharmacy
Academic / other
Locations1 site (Cluj-Napoca)
StatusRecruiting
StartedOctober 2, 2026
Main results expectedOctober 29, 2027
Study endsSeptember 30, 2029
Registry record updatedNovember 4, 2026
Trial IDNCT07907224 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with Stage III/IV periodontitis (Grade B or C) and sufficient dentition for full-mouth evaluation.

Probably not a fit

Individuals without periodontitis or with uncontrolled systemic diseases may not experience any direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will enroll 20 adults with Stage III/IV periodontitis and characterize their oral and gut health using periodontal exams, breath tests for SIBO, and blood tests for gut barrier biomarkers. The study is prospective and exploratory, aiming to describe associations rather than prove causation. Participants will be followed to see if improvements in periodontal health align with changes in SIBO status and biomarker levels. Data on symptoms and lifestyle will help interpret the findings. No healthy control group is included, and results will inform future studies on oral-gut interactions.

Why it matters

Potential benefit: If associations are found, the study could guide future research and inform clinicians about potential gut health considerations for patients with severe periodontitis.

How similar studies have gone: Previous work suggests possible links between oral inflammation and gut microbiota, but human evidence remains preliminary and heterogeneous.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged ≥18 years.
* Diagnosis of Stage III/IV periodontitis, Grade B or C, according to the applicable periodontal classification criteria.
* Presence of sufficient dentition to permit a meaningful full-mouth periodontal examination.
* Ability and willingness to perform the breath test and provide blood samples and questionnaire data.
* Written informed consent.
* Patients with stable chronic systemic conditions may be included, provided that the condition is clinically controlled and does not meet any exclusion criterion. Relevant systemic diseases and concomitant medications will be recorded and considered as potential confounding factors.

Exclusion Criteria:

* Uncontrolled or severe systemic disease likely to substantially affect periodontal inflammation, intestinal microbiota, intestinal barrier function, systemic inflammatory status, or the safety of periodontal treatment.
* Antibiotic, systemic antifungal, or probiotic therapy within the preceding 4 weeks.
* Recent periodontal treatment that could materially influence baseline periodontal or biological measurements.
* Diagnosed inflammatory bowel disease, celiac disease, major intestinal surgery, or another major gastrointestinal condition that would substantially interfere with interpretation of SIBO or intestinal barrier-related outcomes.
* Current pregnancy or breastfeeding.
* Other condition or treatment judged by the investigator to materially interfere with the study outcomes or procedures.

Where it's running

  • Ambulatoriul de Stomatologie al SCJU Cluj-Napoca, România
    Cluj-Napoca, Romania
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.